Ex parte BOLUK et al. - Page 8




          Appeal No. 96-0126                                                          
          Application 07/942,400                                                      


          in appealed claim 1.  Nevertheless, because the ingredients                 
          and concentrations encompassed by this claim correspond to the              
          ingredients and concentrations disclosed by Ma, it is fair to               
          believe that patentee’s compositions contain these recited                  
          characteristics of the here claimed compositions, and it is                 
          fair to require the appellants to shoulder the burden of                    
          proving otherwise.  Whether the rejection is based on                       
          ?inherency? under 35 USC § 102, on ?prima facie obviousness?                
          under 35 USC § 103, jointly or alternatively, the burden of                 
          proof is the same, and its fairness is evidenced by the                     
          inability of the Patent and Trademark Office to manufacture                 
          products or to obtain and compare prior art products.  In re                
          Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433-434 (CCPA 1977).               
               In light of the foregoing, we hereby sustain the                       
          examiner’s § 103 rejection of claim 1 as being unpatentable                 
          over Ma.                                                                    
               For analogous reasons, we also sustain the examiner’s §                
          103 rejection of independent claim 1 and dependent claims 2                 
          through 8 as being unpatentable over Ma and Konig-Lamer in                  
          view of Seaman.  The appellants’ arguments concerning the                   
          Konig-Lamer and Seaman references are not well taken.  In any               
                                          8                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007